Status:
TERMINATED
Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar)
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Weill Cornell Medical College in Qatar
Hamad Medical Corporation
Conditions:
Diabetes Mellitus
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-90 years
Brief Summary
This protocol is designed to gather a small amount of blood for extraction of DNA for the study of the genetic basis of diabetes. The study population will include individuals with known diabetes, and...
Detailed Description
This protocol is designed to collect a small amount of blood for extraction of DNA (genetic material) for the study of the genetic basis of diabetes. The study population will include individuals with...
Eligibility Criteria
Inclusion
- Diabetes group
- Inclusion criteria:
- Must provide informed consent
- Males and females, age 18 years and older
- Documented evidence of diabetes using at least one of the following: (1) blood tests consistent with Type-II diabetes; (2) oral glucose tolerance tests consistent with Type-II diabetes; (3) subject taking medication to treat Type-II diabetes.
- Exclusion criteria:
- Individual refuses consent
- Pregnant females with gestational diabetes
- Type-I diabetes
- Normal control group
- Must provide informed consent
- Males or females ages 18 years and older
- Resolved gestational diabetes
Exclusion
- Individual refuses consent.
- Individuals with history of diabetes.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT01172743
Start Date
June 1 2009
End Date
July 1 2020
Last Update
July 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamad Medical Corporation
Doha, Qatar